Loading chat...
MN HF2803
Bill
Status
5/20/2016
Primary Sponsor
Nick Zerwas
Click for details
AI Summary
-
Prohibits persons subject to emergency admission or apprehend and hold orders from being allowed or required to consent to or participate in clinical drug trials, and voids any consent given during such holds.
-
Permits continued participation in clinical drug trials only if the person was already enrolled at the time the emergency hold or apprehend and hold order was issued.
-
Requires treatment facilities to immediately notify the employing agency of the peace or health officer when a person is released, discharged, or leaves without consent during the 72-hour hold period.
-
Requires courts to make every reasonable effort to notify specific individuals identified as endangered, the examining physician, and the transporting officer before releasing a person held under emergency admission.
-
Clarifies examiner statement requirements to include behavioral terms, sufficient specificity, and identification of specific individuals at risk; requires inquiries into health care directives and advance psychiatric directives.
Legislative Description
Clinical drug trial participation prohibited by persons subject to emergency admission or apprehend and hold orders, and notice requirement for early termination of an emergency admission specified.
Last Action
Secretary of State Chapter 120 05/19/16
5/20/2016